Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis

Anthracycline antibiotics, namely, doxorubicin (DOX) and daunorubicin, are among the most widely used anticancer therapies, yet are notoriously associated with severe myocardial damage due to oxidative stress and mitochondrial damage. Studies have indicated the strong pharmacological properties of B...

Full description

Bibliographic Details
Main Authors: Abdelkader A. Metwally, Samayita Ganguly, Nora Biomi, Mingyi Yao, Tamer Elbayoumi
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/29/5/1155
_version_ 1797264088799117312
author Abdelkader A. Metwally
Samayita Ganguly
Nora Biomi
Mingyi Yao
Tamer Elbayoumi
author_facet Abdelkader A. Metwally
Samayita Ganguly
Nora Biomi
Mingyi Yao
Tamer Elbayoumi
author_sort Abdelkader A. Metwally
collection DOAJ
description Anthracycline antibiotics, namely, doxorubicin (DOX) and daunorubicin, are among the most widely used anticancer therapies, yet are notoriously associated with severe myocardial damage due to oxidative stress and mitochondrial damage. Studies have indicated the strong pharmacological properties of Berberine (Brb) alkaloid, predominantly mediated via mitochondrial functions and nuclear networks. Despite the recent emphasis on Brb in clinical cardioprotective studies, pharmaceutical limitations hamper its clinical use. A nanoformulation for Brb was developed (mMic), incorporating a cationic lipid, oleylamine (OA), into the TPGS-mixed corona of PEGylated-phosphatidylethanolamine (PEG-PE) micelles. Cationic TPGS/PEG-PE mMic with superior Brb loading and stability markedly enhanced both intracellular and mitochondria-tropic Brb activities in cardiovascular muscle cells. Sub-lethal doses of Brb via cationic OA/TPGS mMic, as a DOX co-treatment, resulted in significant mitochondrial apoptosis suppression. In combination with an intense DOX challenge (up to ~50 µM), mitochondria-protective Brb-OA/TPGS mMic showed a significant 24 h recovery of cell viability (<i>p</i> ≤ 0.05–0.01). Mechanistically, the significant relative reduction in apoptotic caspase-9 and elevation of antiapoptotic Bcl-2 seem to mediate the cardioprotective role of Brb-OA/TPGS mMic against DOX. Our report aims to demonstrate the great potential of cationic OA/TPGS-mMic to selectively enhance the protective mitohormetic effect of Brb to mitigate DOX cardiotoxicity.
first_indexed 2024-04-25T00:23:21Z
format Article
id doaj.art-71393793b6974387b3fa3f6874f4fd40
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-04-25T00:23:21Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-71393793b6974387b3fa3f6874f4fd402024-03-12T16:51:18ZengMDPI AGMolecules1420-30492024-03-01295115510.3390/molecules29051155Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding ApoptosisAbdelkader A. Metwally0Samayita Ganguly1Nora Biomi2Mingyi Yao3Tamer Elbayoumi4Department of Pharmaceutics, College of Pharmacy, Health Science Center (HSC), Kuwait University, P.O. Box 24923, Safat 13110, KuwaitParkinson’s Disease Research Unit, Department of Neurobiology, Barrow Neurological Institute, Dignity Health/St. Joseph’s Hospital and Medical Center, 350 W. Thomas Rd., Phoenix, AZ 85013, USAPharmacology and Toxicology Program, New College of Interdisciplinary Arts and Sciences, West Valley Campus, Arizona State University, N. 47th Ave & University Way, Glendale, AZ 85306, USADepartment of Pharmaceutical Sciences, Glendale Campus (CPG), College of Pharmacy, Midwestern University, 218-Cholla Hall, 19555 N. 59th Ave., Glendale, AZ 85308, USADepartment of Pharmaceutical Sciences, Glendale Campus (CPG), College of Pharmacy, Midwestern University, 218-Cholla Hall, 19555 N. 59th Ave., Glendale, AZ 85308, USAAnthracycline antibiotics, namely, doxorubicin (DOX) and daunorubicin, are among the most widely used anticancer therapies, yet are notoriously associated with severe myocardial damage due to oxidative stress and mitochondrial damage. Studies have indicated the strong pharmacological properties of Berberine (Brb) alkaloid, predominantly mediated via mitochondrial functions and nuclear networks. Despite the recent emphasis on Brb in clinical cardioprotective studies, pharmaceutical limitations hamper its clinical use. A nanoformulation for Brb was developed (mMic), incorporating a cationic lipid, oleylamine (OA), into the TPGS-mixed corona of PEGylated-phosphatidylethanolamine (PEG-PE) micelles. Cationic TPGS/PEG-PE mMic with superior Brb loading and stability markedly enhanced both intracellular and mitochondria-tropic Brb activities in cardiovascular muscle cells. Sub-lethal doses of Brb via cationic OA/TPGS mMic, as a DOX co-treatment, resulted in significant mitochondrial apoptosis suppression. In combination with an intense DOX challenge (up to ~50 µM), mitochondria-protective Brb-OA/TPGS mMic showed a significant 24 h recovery of cell viability (<i>p</i> ≤ 0.05–0.01). Mechanistically, the significant relative reduction in apoptotic caspase-9 and elevation of antiapoptotic Bcl-2 seem to mediate the cardioprotective role of Brb-OA/TPGS mMic against DOX. Our report aims to demonstrate the great potential of cationic OA/TPGS-mMic to selectively enhance the protective mitohormetic effect of Brb to mitigate DOX cardiotoxicity.https://www.mdpi.com/1420-3049/29/5/1155anthracycline antibioticsdoxorubicincardiomyopathyapoptosisberberinemitohormetic
spellingShingle Abdelkader A. Metwally
Samayita Ganguly
Nora Biomi
Mingyi Yao
Tamer Elbayoumi
Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis
Molecules
anthracycline antibiotics
doxorubicin
cardiomyopathy
apoptosis
berberine
mitohormetic
title Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis
title_full Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis
title_fullStr Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis
title_full_unstemmed Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis
title_short Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis
title_sort cationic vitamin e tpgs mixed micelles of berberine to neutralize doxorubicin induced cardiotoxicity via amelioration of mitochondrial dysfunction and impeding apoptosis
topic anthracycline antibiotics
doxorubicin
cardiomyopathy
apoptosis
berberine
mitohormetic
url https://www.mdpi.com/1420-3049/29/5/1155
work_keys_str_mv AT abdelkaderametwally cationicvitaminetpgsmixedmicellesofberberinetoneutralizedoxorubicininducedcardiotoxicityviaameliorationofmitochondrialdysfunctionandimpedingapoptosis
AT samayitaganguly cationicvitaminetpgsmixedmicellesofberberinetoneutralizedoxorubicininducedcardiotoxicityviaameliorationofmitochondrialdysfunctionandimpedingapoptosis
AT norabiomi cationicvitaminetpgsmixedmicellesofberberinetoneutralizedoxorubicininducedcardiotoxicityviaameliorationofmitochondrialdysfunctionandimpedingapoptosis
AT mingyiyao cationicvitaminetpgsmixedmicellesofberberinetoneutralizedoxorubicininducedcardiotoxicityviaameliorationofmitochondrialdysfunctionandimpedingapoptosis
AT tamerelbayoumi cationicvitaminetpgsmixedmicellesofberberinetoneutralizedoxorubicininducedcardiotoxicityviaameliorationofmitochondrialdysfunctionandimpedingapoptosis